NRC vs TECH · P/E 46, rev $143.1M vs P/E 65, rev $1.22B
National Research Corp (NRC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
National Research Corp (NRC) is a health information services company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NRC revenue for 2024-12-31 was $143.1M. Net income was $24.8M. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NRC currently screens at market cap $400.0M and trailing P/E 45.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NRC and TECH stock pages for the full models.
Not investment advice.